SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 89 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,000 | -98.5% | 11,967 | -68.8% | 0.00% | – |
Q3 2018 | $65,000 | +58.5% | 38,367 | +68.3% | 0.00% | -100.0% |
Q1 2018 | $41,000 | -43.1% | 22,801 | -30.1% | 0.00% | -33.3% |
Q4 2017 | $72,000 | +41.2% | 32,610 | +83.3% | 0.00% | +50.0% |
Q3 2017 | $51,000 | -74.0% | 17,786 | -59.8% | 0.00% | -77.8% |
Q2 2017 | $196,000 | -49.0% | 44,266 | -46.3% | 0.01% | -47.1% |
Q1 2017 | $384,000 | -9.4% | 82,495 | +18.3% | 0.02% | -32.0% |
Q4 2016 | $424,000 | +221.2% | 69,729 | +189.4% | 0.02% | +177.8% |
Q3 2016 | $132,000 | -32.7% | 24,093 | -53.4% | 0.01% | -30.8% |
Q2 2016 | $196,000 | -27.4% | 51,756 | -47.2% | 0.01% | -40.9% |
Q1 2016 | $270,000 | +114.3% | 97,942 | +340.3% | 0.02% | +120.0% |
Q4 2015 | $126,000 | – | 22,242 | +15563.4% | 0.01% | – |
Q1 2015 | $0 | – | 142 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 7,590,000 | $28,842,000 | 8.26% |
Asymmetry Capital Management, L.P. | 298,190 | $1,133,000 | 2.08% |
ARMISTICE CAPITAL, LLC | 1,330,000 | $5,054,000 | 1.92% |
Belmont Global Advisors, Inc. | 385,000 | $1,463,000 | 1.40% |
Paulson & Co. | 27,756,668 | $105,475,000 | 1.07% |
Trellus Management Company, LLC | 162,900 | $619,000 | 1.01% |
DAFNA Capital Management LLC | 319,563 | $1,214,000 | 0.96% |
PURA VIDA INVESTMENTS, LLC | 350,000 | $1,330,000 | 0.56% |
WALL STREET ASSOCIATES | 269,300 | $1,023,000 | 0.41% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,603,334 | $6,093,000 | 0.34% |